Helios Mid Cap Adds Aurobindo Pharma, PVR Inox and Zetwerk; Exits Park Medi World

Key Takeaways

• Helios Mid Cap Fund introduced three new stocks to its portfolio during October 2026.
• The scheme fully exited Park Medi World after selling 4.89 lakh shares.
• Its AUM stood at ₹2,421 crore as of 31 October 2026, with finance remaining the largest sector allocation.

Helios Mid Cap Fund made three fresh additions to its portfolio in October and completely exited one existing holding, according to its latest monthly portfolio disclosure.

Aurobindo Pharma, PVR Inox and Zetwerk Manufacturing Businesses were added during the month. The fund's total assets under management stood at approximately ₹2,421 crore as of 31 October 2026.

The scheme bought 2.54 lakh shares of Aurobindo Pharma with a reported market value of ₹42.74 crore. It also acquired 11.77 lakh Zetwerk shares and 1.29 lakh shares of PVR Inox.

Helios Mid Cap increased exposure to a further group of existing holdings, including One97 Communications, the parent company of Paytm, and Multi Commodity Exchange of India. Paytm holdings increased to about 5.10 lakh shares from 4.83 lakh, while the MCX position rose to 1.89 lakh shares after the addition of 51,430 shares.

The fund also increased positions in names including AceVector, ITC Hotels, Indian Hotels, Gokaldas Exports, AU Small Finance Bank, Ather Energy, Bosch, Coforge and Sona BLW Precision Forgings.

Park Medi World was the only complete exit highlighted in the disclosure. The fund sold 4.89 lakh shares with a reported market value of ₹13.45 crore. It did not report a partial reduction in any other portfolio holding.

The portfolio contained 77 stocks in October compared with 75 in September. Finance was the largest sector exposure at 16.22%, followed by automobiles and ancillaries at 15.76%, healthcare at 11.21% and information technology at 10.04%.

By market-cap allocation, approximately 65.27% of assets were invested in mid-cap companies, with 27.75% in small caps and 2.98% in large caps. The portfolio changes represent the scheme's October holdings and do not indicate a recommendation on the individual securities.